FTC's Unusual Theory Made Steris Case An Uphill Battle
The Federal Trade Commission's rare merger litigation loss Thursday in its challenge to Steris' $1.9 billion acquisition of Synergy Health stemmed more from the unusual theory the antitrust enforcer used in...To view the full article, register now.
Already a subscriber? Click here to view full article